Latest Breaking News On - Nelabarine - Page 1 : comparemela.com

Investigating the addition of novel agents to cytotoxic chemotherapy may help prevent relapse in patients with T-cell acute lymphoblastic leukemia by bolstering the efficacy of these standard frontline therapies.

New yorkUnited statesUniversity of rochester medical centerKristen odwyerVenetoclax venclextaDepartment of medicineChildren oncology groupMeeting of the society hematologic oncologyKristeno dwyerRochester medical center schoolOncology groupAnnual meetingHematologic oncologySociety of hematologic oncology annual meeting sohoMyelodysplastic syndromeNon hodgkin lymphoma